Companies
10x Genomics
Chromium single-cell and Xenium spatial transcriptomics, releasing breast-cancer reference datasets that align Xenium spatial data with scRNA-seq.
- Country
- United States
- Ticker
- NASDAQ: TXG
ISO 9001
Coverage
| CN | EU | US | |
|---|---|---|---|
| bioinformatics-omics | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Certification | ISO 9001:2015 certified for design, development, manufacturing, distribution, service, and sales. Production environments include ISO 7 and ISO 8 clean room classifications. | content.edgar-online.com |
| Production site | Pleasanton, California; Singapore; and Taiwan. | content.edgar-online.com · firmsworld.com |
| Headcount | 1,306 employees as of December 31, 2024. | content.edgar-online.com |
| Revenue | $642.8 million for the year ended 2025. | content.edgar-online.com |
| Capacity | The company sold 1,007 instruments and 424,000 consumable reactions in 2025; manufacturing facilities include automated production suites for reagents and consumables. | content.edgar-online.com · nasdaq.com · prnewswire.com |
Independent sources: content.edgar-online.com · firmsworld.com · nasdaq.com · prnewswire.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bioinformatics & multi-omics | bioinformatics-omics | Low | → |
| Single-cell omics | bioinformatics-omics | Low | → |
| Spatial transcriptomics & spatial multi-omics | bioinformatics-omics | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.